Variables | Huai’an (n = 252) | Jilin (n = 297) | Anhui (n = 408) | Beijing (n = 332) | p Value |
---|---|---|---|---|---|
Male sex, n | 158 (63%) | 168 (57%) | 257 (63%) | 203 (61%) | 0.274 |
Median age (years) (IQR) | 42 (32–49) | 42 (33–50) | 38 (29–48) | 38 (30–47) | 0.006 |
Median BMI (kg/m2) (IQR) | 23.7 (22.5–25.1) | 23.7 (21.6–26.0) | 22.8 (20.4–25.4) | 23.7 (21.0–26.1) | 0.014 |
Median fasting LSM value (kPa) | 10.4 (6.6–15.3) | 7.9 (5.9–11.8) | 5.7 (4.2–7.5) | 7.8 (5.6–12.4) | < 0.001 |
Median ALT (IU/L) (IQR) | 42 (27–67) | 39 (24–65) | 49 (26–84.5) | 46.2 (25.2–79.4) | 0.046 |
Median AST (IU/L) (IQR) | 35 (27–55) | 32 (25–50) | 34 (23–51) | 33 (25–52) | 0.108 |
Median GGT (IU/L) (IQR) | 46 (24–98) | 37 (21–79) | 31.5 (21–73) | 32 (19–60) | < 0.001 |
Median total bilirubin (IU/L) (IQR) | 15.8 (11.9–21.0) | 14.4 (11.6–21.2) | 17.7 (13.0–23.1) | 14.3 (11.4–20) | 0.654 |
Median platelet counts (109/L) (IQR) | 165 (122–206) | 179 (140–215) | 161.5 (125–204) | 186 (148–225) | 0.148 |
Median APRI (IQR) | 0.64 (0.41–1.35) | 0.51 (0.33–0.84) | 0.55 (0.34–0.92) | 0.50 (0.30–0.76) | < 0.001 |
Median FIB-4 (IQR) | 1.61 (0.99–2.87) | 1.22 (0.82–1.95) | 1.17 (0.74–2.04) | 1.07 (0.73–1.69) | < 0.001 |
Ultrasound size of spleen (mm2) (IQR) | 4410 (3866–5280) | 3780 (2976–4710) | 3468 (3120–3813) | 3620 (2890–4560) | < 0.001 |
Ultrasound diameter of spleen vein (mm) (IQR) | 6 (5.2–7) | 7 (6.7–8) | 9 (8–10) | 7 (6–8) | < 0.001 |
Ultrasound diameter of portal vein (mm) (IQR) | 11 (10–12) | 12 (11–12) | 11 (10–11) | 11 (10–12) | < 0.001 |
Ultrasound velocity of portal vein (m/s) (IQR) | 0.16 (0.14–0.19) | 0.11 (0.10–0.12) | Not reported | Not reported | |
Median size of liver biopsy (mm) (IQR) | 15 (12–16) | 16 (12–19) | 15 (12–20) | 16 (13–18) | < 0.001 |
Metavir fibrosis stage (F0/F1/F2/F3/F4) | 21 (8.3%)/37 (14.7%)/46 (18.3%)/51 (20.2%)/97 (38.5%) | 32 (10.8%)/77 (25.9%)/84 (28.3%)/44 (14.8%)/60 (20.2%) | 10 (2.5%)/144 (35.3%)/129 (31.6%)/66 (16.2%)/59 (14.5%) | 26 (7.9%)/127 (38.3%)/73 (22%)/32 (9.6%)/74 (22.3%) | < 0.001 |
Metavir activity grade (A0/A1/A2/A3) | 50 (19.8%)/106 (42.1%)/72 (28.6%)/24 (9.5%) | 190 (64.0%)/54 (18.2%)/52 (17.5%)/1 (0.3%) | 86 (21.1%)/254 (62.2%)/61 (15.0%)/7 (1.7%) | 13 (3.9%)/154 (46.4%)/114 (34.3%)/51 (15.4%) | < 0.001 |